Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Long-Term Investments (2016 - 2025)

Bio-Techne (TECH) has 12 years of Long-Term Investments data on record, last reported at $234.9 million in Q3 2025.

  • For Q3 2025, Long-Term Investments rose 1466.17% year-over-year to $234.9 million; the TTM value through Sep 2025 reached $234.9 million, up 1466.17%, while the annual FY2025 figure was $236.0 million, 2.62% down from the prior year.
  • Long-Term Investments reached $234.9 million in Q3 2025 per TECH's latest filing, roughly flat from $236.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $255.9 million in Q2 2023 and bottomed at $15.0 million in Q3 2024.
  • Average Long-Term Investments over 3 years is $187.1 million, with a median of $239.2 million recorded in 2024.
  • The widest YoY moves for Long-Term Investments: up 1466.17% in 2025, down 93.95% in 2025.
  • A 3-year view of Long-Term Investments shows it stood at $249.7 million in 2023, then tumbled by 93.99% to $15.0 million in 2024, then soared by 1466.17% to $234.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $234.9 million in Q3 2025, $236.0 million in Q2 2025, and $15.0 million in Q1 2025.